Prosecution Insights
Last updated: July 17, 2026
Application No. 16/384,051

GUIDEWIRE WITH ADJUSTABLE STIFFNESS

Final Rejection §103
Filed
Apr 15, 2019
Priority
Jun 30, 2016 — continuation of 10/258,773
Examiner
TOWA, RENE T
Art Unit
3791
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Cardioguidance Biomedical LLC
OA Round
10 (Final)
49%
Grant Probability
Moderate
11-12
OA Rounds
0m
Est. Remaining
66%
With Interview

Examiner Intelligence

Grants 49% of resolved cases
49%
Career Allowance Rate
375 granted / 767 resolved
-21.1% vs TC avg
Strong +17% interview lift
Without
With
+17.2%
Interview Lift
resolved cases with interview
Typical timeline
4y 3m
Avg Prosecution
25 currently pending
Career history
814
Total Applications
across all art units

Statute-Specific Performance

§101
2.2%
-37.8% vs TC avg
§103
86.9%
+46.9% vs TC avg
§102
4.5%
-35.5% vs TC avg
§112
5.1%
-34.9% vs TC avg
Black line = Tech Center average estimate • Based on career data from 767 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application is being examined under the pre-AIA first to invent provisions. This Office action is responsive to an amendment filed February 3, 2026. Claims 36-41 are pending. Claims 1-35 have been canceled. Claims 36-41 have been amended. Claim Rejections - 35 USC § 103 The text of those sections of Title 35, U.S. Code not included in this action can be found in a prior Office action. Claims 36-37 is/are rejected under 35 U.S.C. 103 as being unpatentable over Heuser (US 2006/0047222) in view of Wijayarathna et al. (US 4,563,181). In regards to claim 36, Heuser discloses a method for using a guidewire system in patient, the method comprising: advancing a tubular member (26, 40) over a guidewire 12 such that at least a proximal portion of the guidewire 12 is disposed within an internal lumen in the tubular member (26, 40) (see at least abstract and figs. 1, 3A-B & 4-5); moving a first handle 54 of the tubular member 26 in a longitudinal direction such that a tapered region 60 of the first handle 54 interlocks with a recess 62 of a second handle 56 of second tubular member 40 to (rotationally) lock the first tubular member 26 to the second tubular member 40 (see also at least abstract, figs. 3A-B & 4-5 and par 0020); PNG media_image1.png 264 586 media_image1.png Greyscale advancing the first tubular member 26 and the guidewire 12 to a target region within a vascular system of the patient (see at least figs. 3A-B & 4-5); and advancing a catheter 58 over the tubular member 26 into the vascular system (e.g., the Office notes that the step does not necessarily require advancing the catheter over both the first and second tubular members) (see at least abstract, figs. 5-6 and par 0019-0020 & 0024). Heuser discloses a method, as described above, that fails to explicitly teach a method comprising a tubular member, wherein the tubular member has a first flexibility and comprises a distal tip having a second flexibility and a second proximal region having a second flexibility, the first flexibility being less than the second flexibility. However, Wijayarathna teaches that it is known to provide a method comprising a tubular member 12, wherein the tubular member 12 has a first flexibility and PNG media_image2.png 220 349 media_image2.png Greyscale comprises a distal tip 18 having a second flexibility and a second proximal region 4 having a second flexibility, the first flexibility being less than the second flexibility (see at least abstract, figs. 1-2 and col. 2, lines 1-19 & 35-47). Therefore, it would have been obvious to one of ordinary skill in the art at the time Applicant’s invention was filed to provide the method of Heuser comprising a tubular member, wherein the tubular member has a first flexibility and comprises a distal tip having a second flexibility and a second proximal region having a second flexibility, the first flexibility being less than the second flexibility as taught by Wijayarathna since such a modification would amount to applying a known technique (i.e., as taught by Wijayarathna) to a known device (i.e., as taught by Heuser) ready for improvement to achieve a predictable result such as providing a catheter having excellent torqueability and pushability while avoiding damage to blood vessels in which the catheter is being inserted (see at least col. 2, lines 35-60 of Wijayarathna)--See KSR, 550 U.S. at___, 82 USPQ2d at 1396 (See MPEP § 214 3 for a discussion of the rationale(s) listed above. See also MPEP § 2144 - §2144.09 for additional guidance regarding support for obviousness determinations). In regards to claim 37, Heuser discloses the method of claim 36, further comprising: advancing the guidewire 12 into the vascular system; and advancing the first tubular member 26 over the guidewire 12 in situ (see at least abstract, figs. 3A-B & 4-6 and par 0019-0020). Claims 38 is/are rejected under 35 U.S.C. 103 as being unpatentable over Heuser (‘222) as modified by Wijayarathna (‘181) further in view of Burney (US 4,986,814). While Heuser discloses a method comprising advancing the first tubular member 26 over the guidewire 12; (rotationally) locking the first tubular member 26 to the guidewire 12; and advancing the first tubular member (i.e., portions 29 & 30 of sleeve 14) and the guidewire 12 together to the target region in the vascular system of the patient (see at least abstract, figs. 3A-B & 4-6 and par 0019-0020), Heuser as modified by Wijayarathna and Kring fails to explicitly teach a method further comprising: advancing the tubular member over the guidewire outside of the patient; locking the tubular member to the guidewire outside of the patient; and advancing the tubular member and the guidewire together to the target region in the vascular system of the patient. However, Burnley teaches that it is known to provide a method further comprising: advancing the first tubular member 36 over the guidewire 26 outside of the patient; locking the first tubular member 36 to the guidewire 26 outside of the patient; and advancing the first tubular member 36 and the guidewire 26 together to the target region (see at least abstract, fig. 1; col. 2, lines 20-65, col. 3, lines 46-58 and col. 4, lines 1-2). Therefore, since Heuser teaches that the first tubular member 26 and guidewire 12 can be coupled together (see at least abstract and par 0020) depending on the desired attributes needed in maneuvering across different types of bends and intersections and along blood vessels of varying sizes to reach the treatment or diagnostic site (see at least par 0003 thereof), it would have been obvious to one of ordinary skill in the art at the time Applicant’s invention was filed to provide the method of Heuser as modified by Wijayarathna further comprising: advancing the first tubular member over the guidewire outside of the patient; locking the first tubular member to the guidewire outside of the patient; and advancing the first tubular member and the guidewire together to the target region, as taught by Burnley, in the vascular system of the patient as taught by Burnley since such a modification would amount to applying a known technique (i.e., as taught by Burnley) to a known device (i.e., as taught by Heuser) ready for improvement to achieve a predictable result such as providing a catheter system the components of which can be locked together for one-step insertion (see at least col. 1, lines 28-32 of Burnley)--See KSR, 550 U.S. at___, 82 USPQ2d at 1396 (See MPEP § 214 3 for a discussion of the rationale(s) listed above. See also MPEP § 2144 - §2144.09 for additional guidance regarding support for obviousness determinations). Claims 39-41 is/are rejected under 35 U.S.C. 103 as being unpatentable over Heuser (‘222) as modified by Wijayarathna (‘181) further in view of Adams (US 5,246,009). In regards to claim 39, Heuser as modified by Wijayarathna and Kring discloses the method of claim 36, that fails to explicitly teach a method wherein a distal portion of the first tubular member comprises a hydrophilic coating. However, Adams teaches that it is known to provide a method wherein a distal portion of the first tubular member comprises a hydrophilic coating (see at least col. 8, lines 48-54). Therefore, it would have been obvious to one of ordinary skill in the art at the time Applicant’s invention was made to provide the method of Heuser as modified by Wijayarathna wherein a distal portion of the first tubular member comprises a hydrophilic coating as taught by Adams in order to reduce friction between coaxially slidable components to facilitate their interaction. In regards to claim 40, Heuser as modified by Wijayarathna discloses the method of claim 36, wherein the outer diameter of the first tubular member is about 0.035 cm. However, Adams teaches that it is known to provide a method wherein the outer diameter of the first tubular member is about 0.035 cm (i.e., 0.014 inch) (see at least fig. 2 and col. 6, lines 48-52). Therefore, it would have been obvious to one of ordinary skill in the art at the time Applicant’s invention was made to provide the method of Heuser as modified by Wijayarathna wherein the outer diameter of the first tubular member is about 0.035 cm as taught by Adams in order to allow said tubular member to be accommodated inside a catheter having a larger inside diameter since Wijayarathna discloses a catheter that is not limited to its disclosed exemplary sizes (see at least par 0037 thereof). In regards to claim 41, Heuser as modified by Wijayarathna discloses the method of claim 36, that fails to explicitly teach a method wherein an inner diameter of the lumen of tubular member is greater than about 0.014 cm. However, Adams teaches that it is known to provide a method wherein an inner diameter of the lumen of the first tubular member 14 is greater than about 0.014 cm (i.e., 0.007 inch or 0.008 inch) (see at least fig. 2 and col. 6, lines 13-29). Therefore, it would have been obvious to one of ordinary skill in the art at the time Applicant’s invention was made to provide the method of Heuser as modified by Wijayarathna wherein an inner diameter of the lumen of the first tubular member 14 is greater than about 0.014 cm as taught by Adams in order to allow said tubular member to accommodate a guidewire having a smaller diameter since Wijayarathna discloses a catheter that is not limited to its disclosed exemplary sizes (see at least par 0037 thereof). Response to Arguments Applicant's arguments filed February 3, 2026 have been fully considered but they are not persuasive. Applicant contends that Heuser “does not teach the step of moving a first handle of the tubular member in a longitudinal direction such that a tapered region of the first handle interlocks with a recess of a second handle of second tubular member to lock the first tubular member to the second tubular member.” The Office respectfully traverses. For example, as shown at least at fig. 1 thereof, Heuser discloses handles (54, 56), wherein handle 54 includes a tapered wing 60 that rotationally interlocks with a recess 62 in handle 56. The instant claim(s) saliently fail(s) to state that the interlocking locks the movement of the handles in a longitudinal direction. In view of the foregoing, the rejections over at least Heuser are maintained. Conclusion THIS ACTION IS MADE FINAL. Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to RENE T TOWA whose telephone number is (313)446-6655. The examiner can normally be reached Mon-Fri, 9:00 AM-5:00 PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jason M. Sims can be reached on 571-272-7540. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /RENE T TOWA/ Primary Examiner, Art Unit 3791
Read full office action

Prosecution Timeline

Show 24 earlier events
Apr 29, 2025
Response Filed
May 12, 2025
Final Rejection mailed — §103
Aug 05, 2025
Response after Non-Final Action
Aug 14, 2025
Request for Continued Examination
Aug 15, 2025
Response after Non-Final Action
Sep 08, 2025
Non-Final Rejection mailed — §103
Feb 03, 2026
Response Filed
Jun 29, 2026
Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12614635
SYSTEMS AND TECHNIQUES FOR ESTIMATING THE SEVERITY OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN A PATIENT
3y 10m to grant Granted Apr 28, 2026
Patent 12605079
SYSTEM AND A METHOD OF DETERMINING A PHYSIOLOGICAL PARAMETER OF A BODY COMPRISING BLOOD PERFUSED TISSUE
9m to grant Granted Apr 21, 2026
Patent 12599332
Non-Invasive Assessment Of Glymphatic Flow And Neurodegeneration From A Wearable Device
1y 12m to grant Granted Apr 14, 2026
Patent 12588861
Wearable Device And Method For Non-Invasive Assessment Of Glymphatic Flow
1y 11m to grant Granted Mar 31, 2026
Patent 12551203
Catheter with Vessel Lining for Cell Collection and Methods for Using Same
7y 1m to grant Granted Feb 17, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

11-12
Expected OA Rounds
49%
Grant Probability
66%
With Interview (+17.2%)
4y 3m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 767 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month